Orphan Drug CAS2079108-44-2 Retifanlimab Powder for Endocrinology and Metabolic Disease

Model NO.
2079108-44-2
Colour
White
Sample
Avaliable
Storage
Cool Dry Place
Application
API Raw Materials
Shelf Life
2 Years
Transport Package
Bag
Specification
25kg/Drum
Trademark
HS
Origin
China
HS Code
2922498590
Production Capacity
50000 Tons/Month
Reference Price
$ 18.00 - 63.00

Product Description

 
Product Description

Application

1. Cancer Treatment: Retifanlimab is used as an immunotherapy for the treatment of various types of cancer. By inhibiting the PD-1 pathway, it enhances the body's immune response against cancer cells, helping to slow tumor growth and improve patient outcomes.

2. Advanced or Metastatic Malignancies: The drug is indicated for the treatment of advanced or metastatic malignancies that have not responded to other therapies or have relapsed after previous treatments.

3. Monotherapy or Combination Therapy: Retifanlimab can be administered as a monotherapy or in combination with other anti-cancer agents, depending on the specific cancer type and treatment strategy.

4. Orphan Drug Status: In some countries, Retifanlimab may have received orphan drug status, providing certain incentives and exclusivity periods for its development and marketing due to its application in treating rare or orphan diseases.

5. Clinical Trials: Ongoing clinical trials continue to explore the drug's potential in treating various types of cancer and its effectiveness in combination with other therapies.

Character
Estrogens 
NO. Name CAS Purity
1 Estrone 53-16-7 99%
2 β-estradiol 50-28-2 99%
3 Estradiol hemihydrate 35380-71-3 99%
4 Estriol 50-27-1 99%
5 17a-estradiol 57-91-0 99%
6 Estradiol Cypionate 313-06-4 99%
7 Estradiol Valerate 979-32-8 99%
8 Estradiol Benzoate 50-50-0 99%
9 Estradiol Enanthate 4956-37-0 99%
10 Estradiol Benzoate Butyrate 63042-18-2 99%
11 Estradiol Dipropionate 113-38-2 99%
12 2-Methoxyestradiol 362-07-2 99%
13 β-Estradiol 17-acetate 1743-60-8 99%
14 Estradiol Undecylate 3571-53-7 99%

Related Product
 
Orphan Drug CAS2079108-44-2 Retifanlimab Powder for Endocrinology and Metabolic Disease
Orphan Drug CAS2079108-44-2 Retifanlimab Powder for Endocrinology and Metabolic Disease


 
Customer Feedback

Orphan Drug CAS2079108-44-2 Retifanlimab Powder for Endocrinology and Metabolic Disease
Orphan Drug CAS2079108-44-2 Retifanlimab Powder for Endocrinology and Metabolic Disease
Orphan Drug CAS2079108-44-2 Retifanlimab Powder for Endocrinology and Metabolic Disease

Campany Introduce


Wuhan Hansheng New Material Technology Co. Ltd is a professional company which specializeds in manufacturing and selling chemical raw materials, chemical products, pharmaceutical intermediates, veterinary medicine intermediates, dye intermediates, pigments, cosmetics raw materials and chemical reagents.
We have long term cooperation pharmaceutical raw material production plant and a reagent research and development center, with a rich professional background and strong competitive advantage. We have a professional and experienced team and we promise clients to provide the best quality, price and service. During the business cooperation with clients, we alway adhere principe of Honesty, Trustworthiness and win-win policy. We guarantee 100% qualification of our products pass through the standard of USA, Mexicao, UK, Australia, Canada, Brazil, France, Germany, Spain, Belgium, Sweden, the Netherlands and so on.

Orphan Drug CAS2079108-44-2 Retifanlimab Powder for Endocrinology and Metabolic Disease
Orphan Drug CAS2079108-44-2 Retifanlimab Powder for Endocrinology and Metabolic Disease
Our Team


Our company has a team of highly qualified people. Team members are young and full of vigor, always uphold the integrity, standard and efficient working principle, with technology to win the market, do our best to provide customers with efficient and fast service. If you need, please contact us and we will solve it for you as soon as possible.

Orphan Drug CAS2079108-44-2 Retifanlimab Powder for Endocrinology and Metabolic Disease
 

Certificate




 

Exhibition



Orphan Drug CAS2079108-44-2 Retifanlimab Powder for Endocrinology and Metabolic Disease
 

Our Advantages
1: Fast and guaranteed shipment (TNT;EMS;FEDEX;DHL;UPS;EUB, special line)
2: Various payment terms accepted (Btc; MoneyGram; WU)
3: Valued package (Paraffin coating; Double aluminum foil bag; Vacuum packaging)
4: Efficient delivery (3-10 DAYS fast delivery service )
5: Best quality (Without any doping, all the products are pure)
6: Good reputation (we have been in this industry for years, earned great trust from our clients from allover the world)
7: Huge Capacity (We have plenty manufacture centers, each day can produce tons of various products.)
8: The most competitive price (manufacture and produce by our own factories)
9: Good service( Perfect professional service team)
10. In the end, we have the most professional experienced and dedicated team here.

 

Orphan Drug CAS2079108-44-2 Retifanlimab Powder for Endocrinology and Metabolic Disease
 

Packaging & Shipping & Payment


Orphan Drug CAS2079108-44-2 Retifanlimab Powder for Endocrinology and Metabolic Disease